Skip to content

2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)

CMS Measure ID: #7 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)"

2023 # 048 Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older

CMS Measure ID: #48 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 048 Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older”

2023 # 050 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older

CMS Measure ID: #50 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Person and Caregiver-CenteredContinue reading “2023 # 050 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older”

2023 # 093 Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use

CMS Measure ID: #93 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: Yes NQS Domain: Efficiency and Cost Reduction Measure Age:Continue reading “2023 # 093 Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use”

2023 # 476 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

eCQM Title Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia eCQM Identifier (Measure Authoring Tool) 771 eCQM Version Number 4.0.000Continue reading “2023 # 476 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia”